2. Aneurysmal Subarachnoid Hemorrhage
aSAH
aSAH is the condition where a brain
aneurysm ruptures and causes
bleeding into the compartment
surrounding the brain.
Subarachnoid hemorrhage (SAH) is a
common and frequently devastating
condition, accounting for ≈5% of all
strokes.
Aneurysmal subarachnoid hemorrhage
(aSAH) is more common in women than
in men as estimated by De Marchis GM
et.al. 2017.
According to Zacharia BE et.al. 2010,
Aneurysmal subarachnoid hemorrhage is
a form of hemorrhagic stroke that affects
up to 30,000 individuals per year in the
United States.
3. 01
02
03
04
05
Market Size of
Aneurysmal
Subarachnoid
Hemorrhage in the
7MM was found to be
XXX in 2016
The market size is
expected to increase
at a significant growth
during the study
period
Upcoming launch of EG-1962
(Edge Therapeutics Inc) for
treating Aneurysmal
Subarachnoid Hemorrhage
shall fuel the growth of the
market
Owing to the launch of
upcoming therapies,
the market size shall
increase during
forecast period (2018-
2027)
The therapies under
development are
focused on novel
approaches to
treat/improve the
disease condition.
MARKET OUTLOOK
Copyright @ 2018 Delveinsight.
4. EMERGING DRUGS
Copyright @ 2018 Delveinsight.
NYMALIZE
EG-1962 CLAZOSENTAN
IdorsiaEdge Therapeutics Inc
Approved by the U.S. Food and Drug Administration
(FDA)
AND MANY MORE…..
UPCOMING DRUGS
• EG-1962
• CLAZOSENTAN
5. MARKET SIZE
Copyright @ 2018 Delveinsight.
According to Zacharia BE et.al. 2010,
Aneurysmal subarachnoid hemorrhage
(aSAH) is a form of hemorrhagic stroke
thataffects up to 30,000 individuals per
year in the United States.
The estimated worldwide incidence of
SAH is 9/100,000 persons/years as per
estimation of Stanlies D’Souza et.al.
2015.
6. COMPLETE INFORMATION
For complete information please click the link below
Click here
Or
write us at
info@delveinsight.com
Copyright @ 2018 Delveinsight.
7. ABOUT DELVEINSIGHT
ABOUT
DELVEINSIGHT
MISSION
VISION
• Delveinsight , market research & consulting firm provides end to end
comprehensive solutions to the life science industry.
• We help our customers in best decision-making through our expertise in
research & analysis & comes out with unmatched data & forecasts.
• To be the most trusted market research & business consulting firm
worldwide.
• To be the renowned & premier data driven solutions providers
among pharma & biotech companies.
Insight across value chain to help organization make important
business decision through the use and analysis of actionable market
intelligence.
Copyright @ 2018 Delveinsight.